
Chandan Healthcare Ltd is Rated Hold by MarketsMOJO
2026-08-07 10:11:24Chandan Healthcare Ltd is currently rated Hold by MarketsMOJO. This rating was last updated on 05 August 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 07 August 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts Amid Bearish Signals
2026-08-07 08:06:51Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some mildly bullish signals on weekly indicators, the overall technical picture suggests caution for investors as the stock faces downward pressure amid a recent downgrade in its Mojo Grade from Sell to Hold.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-06 08:06:35Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent day decline of 2.82%, the stock’s technical indicators present a complex picture, with some signals suggesting mild bullishness while others remain neutral or bearish. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors.
Read full news article
Chandan Healthcare Ltd is Rated Sell
2026-07-27 10:11:24Chandan Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Chandan Healthcare Ltd is Rated Sell
2026-07-16 10:11:13Chandan Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Chandan Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Returns
2026-07-14 08:07:03Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.28%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, reflecting cautious investor sentiment amid broader market challenges.
Read full news article
Chandan Healthcare Ltd Faces Technical Momentum Shift Amid Mixed Market Returns
2026-07-13 08:04:44Chandan Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in its Mojo Grade to Sell, the stock’s price action and momentum oscillators reveal a nuanced picture for investors navigating the hospital sector’s micro-cap landscape.
Read full news article
Chandan Healthcare Ltd Shows Technical Momentum Shift Amid Mixed Returns
2026-07-10 08:05:11Chandan Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is reflected in key indicators such as the MACD, Bollinger Bands, and Dow Theory signals, signalling a potential positive trend reversal despite the company’s micro-cap status and a recent downgrade in its Mojo Grade to Sell.
Read full news article
Chandan Healthcare Ltd Faces Technical Downturn Amid Price Momentum Shift
2026-07-08 08:06:39Chandan Healthcare Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish phase. This change is underscored by a series of technical indicators, including MACD, RSI, and moving averages, which collectively suggest increasing downside pressure on the stock currently priced at ₹234.10.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






